Discover
AUPH
Aurinia Pharmaceuticals Inc.
15.80
1 x 13.91
1 x 18.30
bid
ask
-
1.17
6.89%
1 @ 05:36 AM
15.88 +0.08 (0.51%)
| Ytd | -0.94% | |
| 1y | 111.23% |
15.78
day range
17.12
7.29
52 week range
19.25
| Open | 16.97 | Prev Close | 16.97 | Low | 15.78 | High | 17.12 | Mkt Cap | 2.03B |
| Vol | 2.02M | Avg Vol | 1.41M | EPS | 2.16 | P/E | 7.31 | Forward P/E | 14.13 |
| Beta | 1.43 | Short Ratio | 7.72 | Inst. Own | 60.26% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 15.99 | 200-d Avg | 14.78 | 1yr Est | 17.00 |
AUPH News
zacks.com
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
Indivior, Aurinia, Ironwood, Altimmune and Marker have been highlighted in this Industry Outlook art
zacks.com
5 Small Drug Stocks to Invest in Amid a Biotech Comeback
Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, AUPH, IRWD, ALT and MRKR may pr
benzinga.com
10 Health Care Stocks Whale Activity In Today's Session
benzinga.com
Aurinia Pharmaceuticals' New Analysis Of Aurora 1 Phase 3 Study Of Lupkynis For Lupus Nephritis Show
Hazard ratios (HRs) favored treatment with LUPKYNIS for the following individual components of the c
benzinga.com
Tang Capital Raises Aurinia Pharmaceuticals Holding to 10%
Tang Capital Management, LLC announces that on June 2, 2026, it acquired 206,005 common shares (the